Journal article
2012
APA
Click to copy
Su, Y., Vilgelm, A., Kelley, M., Hawkins, O. E., Liu, Y., Boyd, K., … Richmond, A. (2012). Cancer Therapy : Preclinical RAF 265 Inhibits the Growth of Advanced Human Melanoma Tumors.
Chicago/Turabian
Click to copy
Su, Yingjun, A. Vilgelm, M. Kelley, Oriana E. Hawkins, Yan Liu, K. Boyd, S. Kantrow, et al. “Cancer Therapy : Preclinical RAF 265 Inhibits the Growth of Advanced Human Melanoma Tumors” (2012).
MLA
Click to copy
Su, Yingjun, et al. Cancer Therapy : Preclinical RAF 265 Inhibits the Growth of Advanced Human Melanoma Tumors. 2012.
BibTeX Click to copy
@article{yingjun2012a,
title = {Cancer Therapy : Preclinical RAF 265 Inhibits the Growth of Advanced Human Melanoma Tumors},
year = {2012},
author = {Su, Yingjun and Vilgelm, A. and Kelley, M. and Hawkins, Oriana E. and Liu, Yan and Boyd, K. and Kantrow, S. and Splittgerber, R. and Short, Sarah P. and Sobolik, T. and Zaja-Milatovic, Snjezana and Dahlman, K. and Amiri, K. and Jiang, A. and Lu, P. and Shyr, Y. and Stuart, D. and Levy, S. and Sosman, J. and Richmond, A.}
}
Purpose: The purpose of this preclinical study was to determine the effectiveness of RAF265, a multikinase inhibitor, for treatment of human metastatic melanoma and to characterize traits associated with